Phase I Study of Dasatinib (BMS-354825) and Imatinib in Subjects With Chronic Myeloid Leukemia in Chronic Phase
Clinical trial NCT00324077 · WITHDRAWN
Trial details
- NCT number
- NCT00324077
- Sponsor
- Bristol-Myers Squibb
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-08-01
- Primary completion
- 2007-02-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.